MCAT and Familial prostate cancer: For instance, mutations in MT-CO2, MT-CO3, MT-ATP8 and MT-ND4L genes, HVR1, OHR and conserved sequence block 1 (CSB1) regions could be useful for risk classification in prostate cancer.